Aclarion, Inc. (ACON)
2.34
+0.03
(+1.30%)
USD |
NASDAQ |
Oct 09, 16:00
2.36
+0.02
(+0.85%)
After-Hours: 20:00
Aclarion Enterprise Value : -10.55M for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | -10.55M |
| October 08, 2026 | -10.62M |
| October 07, 2026 | -10.52M |
| October 06, 2026 | -10.67M |
| October 05, 2026 | -10.55M |
| October 02, 2026 | -10.45M |
| October 01, 2026 | -10.30M |
| September 30, 2026 | -10.38M |
| September 29, 2026 | -10.45M |
| September 28, 2026 | -10.30M |
| September 25, 2026 | -9.933M |
| September 24, 2026 | -9.835M |
| September 23, 2026 | -9.072M |
| September 22, 2026 | -9.835M |
| September 21, 2026 | -10.25M |
| September 18, 2026 | -10.11M |
| September 17, 2026 | -9.810M |
| September 16, 2026 | -10.03M |
| September 15, 2026 | -9.860M |
| September 14, 2026 | -9.958M |
| September 11, 2026 | -9.909M |
| September 10, 2026 | -10.06M |
| September 09, 2026 | -10.35M |
| September 08, 2026 | -10.30M |
| September 04, 2026 | -10.52M |
| Date | Value |
|---|---|
| September 03, 2026 | -10.67M |
| September 02, 2026 | -10.62M |
| September 01, 2026 | -10.57M |
| August 31, 2026 | -10.52M |
| August 28, 2026 | -10.40M |
| August 27, 2026 | -10.11M |
| August 26, 2026 | -10.43M |
| August 25, 2026 | -10.18M |
| August 24, 2026 | -9.761M |
| August 21, 2026 | -9.638M |
| August 20, 2026 | -9.687M |
| August 19, 2026 | -9.490M |
| August 18, 2026 | -9.909M |
| August 17, 2026 | -9.490M |
| August 14, 2026 | -10.25M |
| August 13, 2026 | -10.40M |
| August 12, 2026 | -10.60M |
| August 11, 2026 | -10.70M |
| August 10, 2026 | -10.50M |
| August 07, 2026 | -10.67M |
| August 06, 2026 | -10.52M |
| August 05, 2026 | -10.50M |
| August 04, 2026 | -10.45M |
| August 03, 2026 | -10.50M |
| July 31, 2026 | -10.77M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Biotricity, Inc. | 31.67M |
| MedLink International, Inc. | -- |
| Agilent Technologies, Inc. | 50.28B |
| Abbott Laboratories | 200.00B |
| Align Technology, Inc. | 9.186B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.748M |
| Revenue (Quarterly) | 0.0252M |
| Total Expenses (Quarterly) | 2.773M |
| EPS Diluted (Quarterly) | -1.116 |
| Gross Profit Margin (Quarterly) | -212.7% |
| Profit Margin (Quarterly) | -10.90K% |
| Earnings Yield | -324.6% |
| Normalized Earnings Yield | -324.65 |